Skip to content
★ Sign in to follow
PP

Polydex Pharmaceuticals Ltd/Bahamas Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by Usher George G, was filed 27 Aug 2008.

Polydex Pharmaceuticals Ltd/Bahamas: what insiders have been doing

Polydex Pharmaceuticals Ltd/Bahamas is a listed company. Its directors and officers file their transactions with SEC (Form 4). No insider at Polydex Pharmaceuticals Ltd/Bahamas has published a filing in the past twelve months. The most recent one dates from 27 August 2008.

Looking back to 2007, when coverage begins, insiders filed 10 purchases and 1 sale.

These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Insider Decl.
11
Thresholds
n/a
Buy Volume
€46,617
10 ops. · all time
Sell Volume
€17,184
1 ops. · all time

Financial data

· cache

Last declaration on 27 August 2008
Declarations11 total
  • ▲
    President and CEOExecutives
    16,500 USD0SEC
    27,500 shares@ US$0.60Common StockSEC:0001144204-08-050152:0
    Canonical exit: 23 Nov 2008 (T+90)
  • ▲
    President and CEOExecutives
    15,072 USD0SEC
    17,943 shares@ US$0.84Common StockSEC:0001144204-08-010130:0
    Canonical exit: 4 May 2008 (T+90)
  • ▲
    President and CEOExecutives
    2,640 USD0SEC
    3,000 shares@ US$0.88Common StockSEC:0001144204-08-002655:0
    Canonical exit: 13 Apr 2008 (T+90)
  • ▲
    President and CEOExecutives
    1,326 USD0SEC
    1,300 shares@ US$1.0199Common StockSEC:0001144204-08-002141:0
    Canonical exit: 9 Apr 2008 (T+90)
  • ▲
    President and CEOExecutives
    936 USD0SEC
    936 shares@ US$1.00Common StockSEC:0001144204-08-002141:1
    Canonical exit: 9 Apr 2008 (T+90)
  • ▲
    President and CEOExecutives
    3,222 USD0SEC
    3,464 shares@ US$0.93Common StockSEC:0001144204-08-002141:2
    Canonical exit: 9 Apr 2008 (T+90)
  • ▲
    President and CEOExecutives
    186 USD0SEC
    200 shares@ US$0.929Common StockSEC:0001144204-08-002141:3
    Canonical exit: 9 Apr 2008 (T+90)
  • ▲
    President and CEOExecutives
    2,870 USD0SEC
    4,100 shares@ US$0.70Common StockSEC:0001144204-08-002141:4
    Canonical exit: 9 Apr 2008 (T+90)
  • ▲
    President and CEOExecutives
    680 USD0SEC
    1,000 shares@ US$0.68Common StockSEC:0001144204-08-002141:5
    Canonical exit: 9 Apr 2008 (T+90)
  • ▲
    President and CEOExecutives
    23,432 USD0SEC
    13,703 shares@ US$1.71Common StockSEC:0001144204-07-038992:0
    Canonical exit: 24 Oct 2007 (T+90)
  • ▼
    Related company / holdingExecutives
    23,432 USD0SEC
    13,703 shares@ US$1.71Common StockSEC:0001144204-07-038994:0

11 of 11 declarations

About Polydex Pharmaceuticals Ltd/Bahamas

Polydex Pharmaceuticals Ltd/Bahamas is a company focused on the development and manufacturing of pharmaceutical products. It is listed on NASDAQ.